[2025-10-01T20:31:02.995114] [QUERYOME] Starting research for query 765: 'Instructions:
 Answer the question below. First, respond with the single best option letter (A, B, C, or D). Then provide a concise reasoning (1–3 sentences). Use both the retrieved evidence and your own medical knowledge to choose the most accurate answer.

Question:
Latest drug reccntly approved for Amyotrophic Lateral sclerosis is?

Options:
A. Piracetam
B. Ceftriaxone
C. Edaravone
D. Doxycycline'
[2025-10-01T20:31:03.036928] [PI] Starting research for query: 'Instructions:
 Answer the question below. First, respond with the single best option letter (A, B, C, or D). Then provide a concise reasoning (1–3 sentences). Use both the retrieved evidence and your own medical knowledge to choose the most accurate answer.

Question:
Latest drug reccntly approved for Amyotrophic Lateral sclerosis is?

Options:
A. Piracetam
B. Ceftriaxone
C. Edaravone
D. Doxycycline'
[2025-10-01T20:31:03.038307] Saving text to bench_final/run1/medmcqa/medmcqa_2325/pi_initial_prompt.txt
[2025-10-01T20:31:03.043059] [PI] Calling o3 for initial analysis...
[2025-10-01T20:31:10.226951] [PI] Reasoning iteration 1
[2025-10-01T20:31:10.228382] [PI] Executing function call 1: hybrid_search
[2025-10-01T20:31:10.231558] [PI] Function arguments: {'query': 'edaravone FDA approval amyotrophic lateral sclerosis 2017', 'k': 5, 'faiss_weight': 0.6, 'bm25_weight': 0.4, 'use_rrf': True}
[2025-10-01T20:31:10.233578] Saving JSON to bench_final/run1/medmcqa/medmcqa_2325/pi_iteration_1_tool_call_2_hybrid_search.json
[2025-10-01T20:31:11.368515] [PI] Function hybrid_search executed successfully
[2025-10-01T20:31:11.369932] Saving JSON to bench_final/run1/medmcqa/medmcqa_2325/pi_iteration_1_tool_result_2_hybrid_search.json
[2025-10-01T20:31:11.376914] [PI] Continuing reasoning with 1 function responses...
[2025-10-01T20:31:18.111615] [PI] Reasoning iteration 2
[2025-10-01T20:31:18.113284] [PI reasoning] **Clarifying drug information**

I'm focusing on providing the correct information about Edaravone. I remember it's an antioxidant neuroprotective medication that got FDA approval in 2017. This is key because other options, like Ceftriaxone, aren't approved for ALS. So, I'll state confidently that C is the answer. It seems like adding citations is important too, so I'll ensure I include those to back up my points.
[2025-10-01T20:31:18.115030] [PI] No function calls found in response
[2025-10-01T20:31:18.117462] [PI] No more function calls - research complete
[2025-10-01T20:31:18.119087] Saving text to bench_final/run1/medmcqa/medmcqa_2325/pi_final_answer.txt
[2025-10-01T20:31:18.123756] [QUERYOME] Query completed successfully
